J. Biol. Chem., Vol. 260, Issue 30, 16274-16278, Dec, 1985
Thymidine incorporation in nucleoside transport-deficient lymphoma cells
B Aronow and B Ullman
Nucleoside transport deficiency in mammalian cells is associated with an
inability to transport most nucleosides, growth resistance to a spectrum of
cytotoxic nucleosides, and a loss of binding sites for 4-
nitrobenzylthioinosine (NBMPR), a potent inhibitor of nucleoside transport.
The nucleoside transport-deficient S49 T lymphoma cell line, AE1, however,
was almost as capable of incorporating thymidine into TTP as the wild type
parent provided thymidine was administered at a sufficiently high
concentration. Consequently, AE1 cells were just as sensitive as wild type
cells to the toxicity of high thymidine concentrations. In contrast, AE1
cells were highly resistant to almost all other cytotoxic nucleosides
including the thymidine analogs, 5- bromodeoxyuridine and
5-fluoro-2'-deoxyuridine 5'-monophosphate. Despite having demonstrable
ability to accumulate TTP, AE1 cells were unable to grow on
hypoxanthine-amethopterin-thymidine (HAT)-containing medium. This was due
to their inability to accumulate sufficient TTP from the low concentrations
of thymidine present in HAT medium. AE1 cells possessed an incomplete
thymidine transport deficiency, the extent of which was concentration
dependent. The residual capacity for thymidine transport present in AE1
cells was insensitive to inhibition by 4-nitrobenzylthioinosine and could
account both for their inability to grow on HAT medium and their
sensitivity to cytotoxic concentrations of thymidine. Another nucleoside
transport-deficient cell line, FURD-80- 3-6, was similar to the AE1 cell
line in its growth phenotype and NBMPR- binding site deficiency but
differed in its decreased growth sensitivity to thymidine. That nucleoside
transport deficiencies may vary in their completeness for different
nucleosides has significance for the mechanism by which a single
transporter can recognize a wide variety of nucleosides.